Research on quaternary ammonium compounds (QACs) has shown promising results in combating MRSA infections. Studies have found that QACs are effective in killing MRSA bacteria by disrupting their cell membranes. Various methodologies, including in vitro and in vivo experiments, have demonstrated the efficacy of QACs in reducing MRSA colonization and infection rates. The implications of these findings suggest that QACs could be a valuable tool in preventing and treating MRSA infections, especially in healthcare settings where antibiotic resistance is a growing concern. Further research is needed to explore the potential of QACs as a viable alternative to traditional antibiotics in the fight against MRSA.